Phase II Study of Adjuvant Chemotherapy Comprising Capecitabine and Ge
- This topic has 4 replies, 3 voices, and was last updated 12 years, 5 months ago by
.
-
Posts
-
Eli…thanks for pointing this out. Negative margins patients have reached the accrual strata hence the trial remains open only to the positive margins patients.
It appears that this trial will reach complete accrual status within the next few months.
Hugs and love,
MarionThey are no longer enrolling negative margins (R0) patients.
Quote:
Quote:R0 stratum closed as of 12-15-11The trial is still open to positive margins (R1) patients.
Thanks, Gavin.
Note: Disease has to be extrahepatic,
Patient has to have undergone potentially curative radical resection within 56 days
Those with microscopically positive margins are included
resected lympnodes (regional) can be positiveDue to the fact that this is a rather large, multi-institutional study, patients should have a high likelihood of finding a center nearby.
For those contemplating speaking with their physicians please, know that clinical trials (first and foremost) are designed to further research into a specific disease.
The benefit of entering into a clinical trial “may” allow for the possibility of benefitting from such study.
Hugs and love,
MarionPhase II Study of Adjuvant Chemotherapy Comprising Capecitabine and Gemcitabine Hydrochloride Followed By Capecitabine and Radiotherapy in Patients With Extrahepatic Cholangiocarcinoma of the Gallbladder or Bile Duct
- The forum ‘Clinical Trials’ is closed to new topics and replies.